VAPEC-B regimen: Difference between revisions
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} ==Overview== {{PAGENAME}} refers to a regimen consisting of vincristine, doxorubicin (adriamycin), prednisolon...") |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[vincristine]], [[doxorubicin|doxorubicin (adriamycin)]], [[prednisolone]], [[etoposide]], [[cyclophosphamide]], [[bleomycin]]used to treat [[non-Hodgkin's lymphoma]] (NHL).<ref name="pmid8590697">{{cite journal| author=Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR et al.| title=VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. | journal=Clin Oncol (R Coll Radiol) | year= 1995 | volume= 7 | issue= 6 | pages= 366-70 | pmid=8590697 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8590697 }} </ref> | {{PAGENAME}} refers to a regimen consisting of [[vincristine]], [[doxorubicin|doxorubicin (adriamycin)]], [[prednisolone]], [[etoposide]], [[cyclophosphamide]], [[bleomycin]]used to treat [[non-Hodgkin's lymphoma]] (NHL).<ref name="pmid8590697">{{cite journal| author=Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR et al.| title=VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. | journal=Clin Oncol (R Coll Radiol) | year= 1995 | volume= 7 | issue= 6 | pages= 366-70 | pmid=8590697 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8590697 }} </ref> | ||
==Regimen== | ==Regimen== | ||
{{chemo|V|Vincristine}} | {{chemo|V|Vincristine}} | ||
| Line 23: | Line 20: | ||
==Indications== | ==Indications== | ||
*[[Non-Hodgkin's lymphoma]]<ref name="pmid8590697">{{cite journal| author=Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR et al.| title=VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. | journal=Clin Oncol (R Coll Radiol) | year= 1995 | volume= 7 | issue= 6 | pages= 366-70 | pmid=8590697 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8590697 }} </ref> | *[[Non-Hodgkin's lymphoma]]<ref name="pmid8590697">{{cite journal| author=Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR et al.| title=VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. | journal=Clin Oncol (R Coll Radiol) | year= 1995 | volume= 7 | issue= 6 | pages= 366-70 | pmid=8590697 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8590697 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 14:32, 30 March 2015
|
WikiDoc Resources for VAPEC-B regimen |
|
Articles |
|---|
|
Most recent articles on VAPEC-B regimen Most cited articles on VAPEC-B regimen |
|
Media |
|
Powerpoint slides on VAPEC-B regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on VAPEC-B regimen at Clinical Trials.gov Trial results on VAPEC-B regimen Clinical Trials on VAPEC-B regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on VAPEC-B regimen NICE Guidance on VAPEC-B regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on VAPEC-B regimen Discussion groups on VAPEC-B regimen Patient Handouts on VAPEC-B regimen Directions to Hospitals Treating VAPEC-B regimen Risk calculators and risk factors for VAPEC-B regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for VAPEC-B regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
VAPEC-B regimen refers to a regimen consisting of vincristine, doxorubicin (adriamycin), prednisolone, etoposide, cyclophosphamide, bleomycinused to treat non-Hodgkin's lymphoma (NHL).[1]
Regimen
VVincristine
ADoxorubicin (Adriamycin)
PPrednisolone
EEtoposide
CCyclophosphamide
BBleomycin
Indications
References
- ↑ 1.0 1.1 Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR; et al. (1995). "VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients". Clin Oncol (R Coll Radiol). 7 (6): 366–70. PMID 8590697.